These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2548550)

  • 1. Chemical design of cilazapril.
    Attwood MR
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):133S-137S. PubMed ID: 2548550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformationally restricted inhibitors of angiotensin converting enzyme: synthesis and computations.
    Thorsett ED; Harris EE; Aster SD; Peterson ER; Snyder JP; Springer JP; Hirshfield J; Tristram EW; Patchett AA; Ulm EH
    J Med Chem; 1986 Feb; 29(2):251-60. PubMed ID: 3005569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the preclinical cardiovascular pharmacology of cilazapril, a new angiotensin converting enzyme inhibitor.
    Waterfall JF
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):139S-150S. PubMed ID: 2527528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New potent inhibitors of angiotensin converting enzyme.
    Attwood MR; Francis RJ; Hassall CH; Kröhn A; Lawton G; Natoff IL; Nixon JS; Redshaw S; Thomas WA
    FEBS Lett; 1984 Jan; 165(2):201-6. PubMed ID: 6319181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril.
    Essig J; Belz GG; Wellstein A
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):217S-223S. PubMed ID: 2548551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enalaprilat, but not cilazaprilat, increases inflammatory skin reactions in guinea-pigs.
    Andersson RG; Karlberg BE; Lindgren BR; Persson K; Rosenqvist U
    Drugs; 1991; 41 Suppl 1():48-53. PubMed ID: 1712272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics and dose proportionality of cilazapril.
    Massarella J; DeFeo T; Lin A; Limjuco R; Brown A
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):199S-204S. PubMed ID: 2527533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics and bioavailability of cilazapril in normal man.
    Williams PE; Brown AN; Rajaguru S; Francis RJ; Walters GE; McEwen J; Durnin C
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):181S-188S. PubMed ID: 2527531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ACE inhibition with cilazapril on splanchnic and systemic haemodynamics in man.
    Gasic S; Heinz G; Kleinbloesem C; Korn A
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):225S-234S. PubMed ID: 2548552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics and angiotensin converting enzyme inhibition dynamics of cilazapril in essential hypertension.
    Meredith PA; Elliott HL; Reid JL; Francis RJ
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):263S-266S. PubMed ID: 2548553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacokinetic study of cilazapril in elderly and young volunteers.
    Williams PE; Brown AN; Rajaguru S; Walters GE; McEwen J; Durnin C
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):211S-215S. PubMed ID: 2527535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacokinetic study of cilazapril in patients with congestive heart failure.
    Rosenthal E; Francis RJ; Brown AN; Rajaguru S; Williams PE; Steiner J; Curry PV
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):267S-273S. PubMed ID: 2548554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of food on the pharmacokinetics and ACE inhibition of cilazapril.
    Massarella JW; DeFeo TM; Brown AN; Lin A; Wills RJ
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):205S-209S. PubMed ID: 2527534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,2-Cyclomethylenecarboxylic monoamide hydroxamic derivatives. A novel class of non-amino acid angiotensin converting enzyme inhibitors.
    Turbanti L; Cerbai G; Di Bugno C; Giorgi R; Garzelli G; Criscuoli M; Renzetti AR; Subissi A; Bramanti G; DePriest SA
    J Med Chem; 1993 Mar; 36(6):699-707. PubMed ID: 8459398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and enzyme inhibitory activities of new trifluoromethyl-containing inhibitors for angiotensin converting enzyme.
    Ojima I; Jameison FA; Pete B; Radunz H; Schittenhelm C; Lindner HJ; Emith AE
    Drug Des Discov; 1994 Feb; 11(2):91-113. PubMed ID: 8075303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis of novel Triazolones and bis-Triazolones derivatives under ultrasound irradiation and evaluation as potent angiotensin converting enzyme (ACE) inhibitors.
    Ben Salah B; Hamzaoui S; Krichen F; Saadaoui I; Ben Mansour R; Miled N; Bougatef A; Kossentini M
    Bioorg Chem; 2018 Feb; 76():147-153. PubMed ID: 29175586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The design of a new group of angiotensin-converting enzyme inhibitors.
    Hassall CH; Kröhn A; Moody CJ; Thomas WA
    FEBS Lett; 1982 Oct; 147(2):175-9. PubMed ID: 6293868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cilazapril during repeated oral dosing in healthy young volunteers.
    Williams PE; Brown AN; Rajaguru S; Francis RJ; Bell AJ; Dewland PM
    Eur J Drug Metab Pharmacokinet; 1990; 15(1):63-7. PubMed ID: 2166672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of cilazapril.
    Kleinbloesem CH; van Brummelen P; Francis RJ; Wiegand UW
    Drugs; 1991; 41 Suppl 1():3-10. PubMed ID: 1712269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular angiotensin converting enzyme activity in spontaneously hypertensive rats and its inhibition with cilazapril.
    Nakamura Y; Nakamura K; Matsukura T; Nakamura K
    J Hypertens; 1988 Feb; 6(2):105-10. PubMed ID: 2832472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.